The pre-IND meeting provided an opportunity for the Company to discuss its Investigational New Drug (IND) development plan and receive FDA guidance on nonclinical and clinical study requirements for ...
Needham 24 th Annual Virtual Healthcare Conference: Zymeworks’ management will participate in virtual one-on-one meetings and present on April 8 at 9:30 am Eastern Time (ET). Stifel 2025 Virtual ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced ...
Dr. Thierry Jacquemin Expands His Innovative Approach to Health, Performance, and Aesthetic Wellness
As demand for personalized, science-backed wellness solutions continues to rise, Dr. Thierry Jacquemin is expanding his ...
Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...
The Company previously announced first-in-human use of the ARC-IM Thoracic Lead in May 2023. The ARC-IM Thoracic Lead is optimized for placement in the thoracic region of the spinal cord; it will be ...
Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...
Paris, March 26, 2025. The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on ...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for ...
Sight Sciences’ management is scheduled to present on Tuesday, April 8, 2025, at 12:45 pm PT / 3:45 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...
Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of SYMVESS™ in the vascular trauma indication, the development of the product candidates ...
The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback